Personal CFO Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
11,831
+8,720
+280% +$1.34M 0.25% 65
2025
Q4
$429K Buy
3,111
+551
+22% +$72.2K 0.07% 264
2025
Q3
$328K Buy
2,560
+440
+21% +$53.7K 0.06% 321
2025
Q2
$257K Sell
2,120
-901
-30% -$102K 0.05% 381
2025
Q1
$337K Sell
3,021
-1,887
-38% -$201K 0.07% 283
2024
Q4
$478K Sell
4,908
-92
-2% -$9.81K 0.09% 212
2024
Q3
$575K Sell
5,000
-1,200
-19% -$136K 0.08% 230
2024
Q2
$660K Buy
6,200
+832
+15% +$83.5K 0.1% 193
2024
Q1
$519K Buy
5,368
+277
+5% +$28.4K 0.08% 242
2023
Q4
$514K Buy
+5,091
New +$491K 0.09% 218
2021
Q4
Sell
-3,322
Closed -$272K 503
2021
Q3
$272K Buy
3,322
+856
+35% +$77K 0.06% 319
2021
Q2
$225K Sell
2,466
-398
-14% -$35.4K 0.05% 380
2021
Q1
$245K Sell
2,864
-31
-1% -$2.78K 0.05% 322
2020
Q4
$273K Sell
2,895
-1,661
-36% -$145K 0.07% 264
2020
Q3
$0 Buy
4,556
+100
+2% +$8.66K ﹤0.01% 273
2020
Q2
$389K Buy
4,456
+256
+6% +$22.1K 0.12% 167
2020
Q1
$346K Buy
4,200
+1,103
+36% +$98.4K 0.12% 152
2019
Q4
$293K Buy
3,097
+31
+1% +$2.78K 0.08% 215
2019
Q3
$266K Buy
+3,066
New +$275K 0.11% 218

Other funds holding NVS

Personal CFO Solutions's NVS Position: Q1 2026 in Review

Personal CFO Solutions increased its Novartis (NVS) stake by 280% in Q1 2026, buying an estimated $1.34M and bringing the position to 11,831 shares worth $1.81M. The position accounts for 0.25% of the portfolio, ranked #65.

Personal CFO Solutions first reported a position in NVS in Q3 2019 and has held it in 19 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Personal CFO Solutions held 11,831 shares of Novartis worth $1.81M as of Q1 2026.
  • Personal CFO Solutions bought 8,720 Novartis shares in Q1 2026, an estimated $1.34M.
  • Novartis made up 0.25% of Personal CFO Solutions's portfolio in Q1 2026, its #65 holding.
  • Personal CFO Solutions first reported a position in Novartis in Q3 2019 and has held it in 19 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.